Why Second Clinical Reviews Matter in Specialty Care
By Caitlin M. Quinn, MSN, BSN, RN, NEA-BC
Chief Nursing Executive, PriceMDs
Some of the most consequential moments in healthcare occur during periods of relative stability. When treatment plans are progressing as designed and patients are feeling confident that everything is on track.
For clinicians, it is these periods that still deserve close attention. Many specialty and oncology therapies place steady demands on the body. Their effects accumulate over time, and the body’s tolerance can change quickly as a result. When lab values begin to drift, patients may not feel any different, but the underlying risk can unknowingly increase.
This is where a second clinical review can play a meaningful and often critical role in patient safety.
Redundancy in Care is Not a Waste, It is a Powerful Safety Net
One recent oncology case made this abundantly clear.
A patient was taking an oral cancer medication that requires regular lab monitoring. Bloodwork was drawn as scheduled, and results were documented and available to her treating physician as normal. From the outside, the process was completed. From the patient’s perspective, her care felt stable.
But as part of a routine second clinical review during a medication refill, one of our physicians looked closely at her existing lab results and noticed a platelet count that had fallen below a safe range. Platelets are necessary for blood clotting, so when levels drop too low, the risk for bleeding increases.
The concerning detail was timing. The lab value was not new. It had been present weeks earlier and had already been reviewed, but an adjustment to the medication regimen in response to that trend had not been made.
A nurse on our team contacted the treating physician’s office, and the two spoke directly. After reviewing the labs together, they adjusted the treatment plan that same day. Because a second clinical review reconnected data to decision-making, the patient avoided potential serious complications.
Great Care Can Still Leave Gaps
Cases like this are rarely the result of indifference or lack of expertise. They reflect how modern care functions under real conditions.
Clinicians manage large patient panels and continuous streams of data. Many minor lab abnormalities are normal and expected and do not necessarily require immediate action. When a patient appears clinically stable, there is a natural tendency to continue what has been working. We know the phrase, ‘if it’s not broke, don’t fix it.’
But the system isn’t perfect, and there is room for error because in complex specialty care, stability can be misleading. Documentation can give the impression that an issue has been addressed when it has only been acknowledged. Over time, subtle changes lose urgency, particularly when they do not coincide with new symptoms.
A Second Set of Eyes Can Save Lives
Enter the second clinical review.
A second clinical review changes how information is encountered. It provides distance from the original moment of review and allows the data to be considered again, without the same pressures or assumptions.
In specialty care, treatment plans are meant to evolve. Dosing and timing need to respond to how a patient’s body is tolerating therapy, not just to whether a medication remains appropriate. Second clinical reviews create accountability for that reassessment.
In this case, no additional testing was required. The difference came from recognizing that an existing lab trend should have prompted a clinical change.
Eliminate the ‘Middle Man’
What allowed this situation to be addressed quickly was direct communication between clinicians. Two physicians reviewed the same clinical information and discussed the patient’s current regimen in a peer-to-peer exchange, coordinated by a PriceMDs Nurse Navigator who oversaw the process and supported the patient throughout. The conversation stayed focused on the data and the appropriate next step.
When these exchanges are part of routine practice, reassessment feels normal rather than corrective. That makes it easier to address concerns early, before adjustments become more complicated.
Patients Often Don’t Realize How Close They Are to Harm
Patients experience care through instructions and next steps:
- Take this medication
- Get labs drawn
- Refill your prescription
When those steps proceed smoothly, it reinforces the sense that care is progressing as intended.
Patients are not positioned to track lab trends or anticipate medication-related risk on their own. They rely on care teams to monitor results and intervene when necessary. Many of the most important safety measures happen behind the scenes, by design, to help ensure care remains consistent and reliable.
As specialty care becomes more distributed across providers, pharmacies, and systems, responsibility can become diffuse, even when everyone is doing their job well.
The second clinical review addresses that gap. It reintroduces ownership at moments that otherwise pass without pause and protects patients during periods that feel uneventful, when risk is easiest to overlook.
The smallest catch can change everything by creating the opportunity to adjust care early and continuously, while options remain open and intervention is still straightforward.
